Related Experiment Video

Updated: Aug 11, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

A rotavirus vaccine for infants: the Asian experience

K B Phua1, S C Emmanuel, P Goh

  • 1Department of Pediatrics, KK Women's and Children's Hospital, Singapore. kbphua@kkh.com.sg

Annals of the Academy of Medicine, Singapore
|February 14, 2006
PubMed

Insights

The Rotarix vaccine, using the RIX4414 strain, is safe and highly immunogenic in infants. It effectively reduces severe rotavirus gastroenteritis, showing promise for global child health.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Infectious Diseases

Background:

  • Rotavirus gastroenteritis poses a significant global health burden, particularly in developing nations.
  • A live attenuated vaccine, Rotarix (RIX4414 strain, G1P1A P[8]), has been developed to combat this disease.
  • Infant trials for Rotarix are underway globally, with a focus on its efficacy and safety.

Purpose of the Study:

  • To review the safety and immunogenicity of the Rotarix vaccine (RIX4414).
  • To assess the vaccine's effectiveness in preventing severe rotavirus gastroenteritis.
  • To evaluate the prospects of Rotarix in Asia and other developing regions.

Main Methods:

  • A comprehensive review of completed RIX4414 clinical trials.
  • Analysis of safety, reactogenicity, and immunogenicity data from infant studies.
  • Evaluation of vaccine efficacy in diverse epidemiological settings.

Main Results:

  • Rotarix demonstrated a favorable safety profile, comparable to placebo, with high infant immunogenicity (98.8%-100% vaccine take).
  • The vaccine did not interfere with the immune response to routine infant vaccinations.
  • Significant reduction in severe rotavirus gastroenteritis was observed, even with co-circulating serotypes like G9.

Conclusions:

  • The Rotarix vaccine shows encouraging safety and efficacy, warranting further global evaluation.
  • Continued large-scale Phase III trials are ongoing, especially in developing countries with high rotavirus burden.
  • The vaccine holds significant potential for reducing rotavirus morbidity and mortality worldwide.
Abstract

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...